ReSS Abstracts

Updated:Aug 18,2015


ReSS Abstracts

When and Where

Nov. 7-9

Orlando, Fla.
Abstract Submission

All abstract submissions are now closed.

Registration Information

Registration is now open!

Register Online and Save $20
Related Councils

Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation

 

Abstracts

Late Breaking Basic Science Submission and Late Breaking Resuscitation Science Submission are now open. The deadline for submissions is August 19.

What's New

New in 2015:
Abstract submission has been streamlined. There is one abstract submission site, and you will submit each abstract once.

  • It is important that you select the correct abstract category for your abstract, as this will determine if your abstract will be considered for ReSS or Scientific Sessions.
  • If you are submitting more than one abstract, you may select either a Scientific Sessions category or a ReSS category for each abstract you submit.
  • For consideration at ReSS, be sure to select a category under 24. Resuscitation Science Symposium.
  • For consideration at Scientific Sessions, be sure to select a category other than Resuscitation that best aligns with your abstract.

Abstract Submission Period

 


Questions about submitting your abstract or other science? Follow these handy tip sheets:


Scientific Sessions: Why Submit?

Opportunity for Publication:

  • Accepted abstracts are published in Circulation, an American Heart Association journal. Circulation continues to be one of the top journals for Impact Factor, 5-Year Impact Factor, Article Influence® Score, and Eigenfactor® Score and total cites among all 125 journals in the Cardiac & Cardiovascular Systems and 65 journals in the Peripheral Vascular Diseases subject categories, according to the 2013 Journal Citation Reports® (Thomson Reuters, 2014).

Member Benefits:

  • Member benefits include more than $160,000.00 in council awards and travel grants available to professional members, early career investigators, trainees and students submitting abstracts to Scientific Sessions. Visit my.americanheart.org  and view the Awards & Lectures available for Scientific Sessions. To join AHA membership please visit my.americanheart.org/membership.

Global Reach:

  • Your accepted abstracts could receive international coverage from major media outlets.
  • 2014 abstracts were featured in the Associated Press, USA Today, Fox News, BBC, MSNBC.com, Reuters wire service and U.S. News & World Report.
  •  In all, there were more than 2.5 billion media impressions for Scientific Sessions 2014, with more than 15.6 million impressions made from news-related social media events.
  •  Discuss your study findings with more than 17,000 attendees on-site and share your findings with more than 2.5 million virtual professional attendees.

 

Late-Breaking

Late-Breaking Basic Science

These innovative abstracts will provide the latest breakthroughs in basic science, presenting cutting-edge, exciting and pivotal research results.  The submission period is July 27 – Aug. 19, 2015. Select the button below for more information (PDF).

Late-Breaking Basic Science Submission Guidelines (PDF)

Late-Breaking Clinical Trials

Late-Breaking Clinical Trials sessions are innovative, provide the latest breakthroughs in clinical science and potentially will have a significant impact on clinical practice.  Clinical Science Report sessions will highlight trial updates, registries and important clinical science.   The submission period is June 1 – June 24, 2015. Click the button below for more information (PDF).

Late-Breaking Clinical Trials Submission Guidelines (PDF)

Embargo Policy

Abstracts and presentations are embargoed for release at date and time of presentation or time of AHA news event. Written embargoed information cannot be shared with anyone but one-on-one embargoed media interviews can be conducted as long as the reporter agrees to abide by the embargo policy. Failure to honor embargo policies will result in the abstract being withdrawn and barred from presentation. View the complete AHA/ASA General Embargo Policies.